Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 16954223
Shin EY, et al. (2006) betaPak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth. J Biol Chem 281, 35954-64 16954223
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S703-p - ARHGEF7 (human)
Modsite: EEFAsRkstAALEED SwissProt Entrez-Gene
Orthologous residues
ARHGEF7 (human): S703‑p, ARHGEF7 iso1 (human): S525‑p, ARHGEF7 iso5 (human): S610‑p, ARHGEF7 (mouse): S682‑p, ARHGEF7 iso2 (mouse): S682‑p, ARHGEF7 iso3 (mouse): S607‑p, ARHGEF7 (rat): S525‑p, ARHGEF7 (cow): S653‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  adrenal cancer, pheochromocytoma
Relevant cell lines - cell types - tissues:  PC-12 (chromaffin)
Cellular systems studied:  cell lines
Species studied:  rat
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
FGF2 increase
Downstream Regulation
Effect of modification (function):  activity, induced, molecular association, regulation
Effect of modification (process):  cytoskeletal reorganization
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
RAP1GDS1 (human) Disrupts pull-down assay
Comments:  activates ARHGEF7's exchange activity on Rac1

T704-p - ARHGEF7 (human)
Modsite: EFAsRkstAALEEDA SwissProt Entrez-Gene
Orthologous residues
ARHGEF7 (human): T704‑p, ARHGEF7 iso1 (human): T526‑p, ARHGEF7 iso5 (human): T611‑p, ARHGEF7 (mouse): T683‑p, ARHGEF7 iso2 (mouse): T683‑p, ARHGEF7 iso3 (mouse): T608‑p, ARHGEF7 (rat): T526‑p, ARHGEF7 (cow): T654‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  adrenal cancer, pheochromocytoma
Relevant cell lines - cell types - tissues:  PC-12 (chromaffin)
Cellular systems studied:  cell lines
Species studied:  rat
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
FGF2 increase
Downstream Regulation
Effect of modification (function):  activity, induced, molecular association, regulation
Effect of modification (process):  cytoskeletal reorganization
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
RAP1GDS1 (human) Disrupts pull-down assay
Comments:  activates ARHGEF7's exchange activity on Rac1